Prevalence of Anti-HCV in Hemodialysis Patients in Taegu and Kyeongbuk, Korea / 대한내과학회지
Korean Journal of Medicine
;
: 640-646, 1998.
Artículo
en Coreano
| WPRIM
| ID: wpr-196289
ABSTRACT
To determine the prevalence and risk factor of anti-HCV in ESRD patients under chronic maitenance hemodialysis, the prevalence of serum antibodies to hepatitis C Virus(Anti-HCV) was assessed by an enzyme immunoassay (Abbott HCV EIA) in 253 patients with long-term Hemodialysis in Daegu & Kyoungbuk. 15 patients(5.9%) were anti-HCV positive. All dialysis patients had the history of transfusion. The number of transfusion units was not significant in anti-HCV positive patients(mean 17+/-20 pints) in comparison with the number in anti-HCV negative patients (mean 16+/-17 pints). The frequency of hemodialysis was also not significant in anti-HCV positive patients(mean 477+/-618 ) compared with anti-HCV negative patients (mean 462+/-616). The mean duration of hemodialysis was significantly higher(P<0.001) in the anti-HCV positive patients (74+/-42 months) in comparison with anti-HCV negative patients (45+/-41 months). We concluded that the prevalence of anti-HCV in hemodialysis patients is 5.9% and that HCV infection is significantly related with the duration of hemodialysis rather than the number of transfusion units and the frequency of hemodialysis
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Prevalencia
/
Factores de Riesgo
/
Técnicas para Inmunoenzimas
/
Diálisis Renal
/
Hepatitis C
/
Hepacivirus
/
Diálisis
/
Fallo Renal Crónico
/
Corea (Geográfico)
/
Anticuerpos
Tipo de estudio:
Estudio de etiología
/
Estudio de prevalencia
/
Factores de riesgo
Límite:
Humanos
País/Región como asunto:
Asia
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Año:
1998
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS